Alpine Immune Sciences, Inc. (ALPN) Financials
ALPN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 240.5 million | 78.9 million |
2023-06-30 | 252.8 million | 83.4 million |
2023-03-31 | 262.1 million | 92.6 million |
2022-12-31 | 286.7 million | 107.3 million |
ALPN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -15.8 million | 2.7 million |
2023-06-30 | -18.4 million | 2.6 million |
2023-03-31 | -26.2 million | 2.6 million |
2022-12-31 | -16.9 million | 2.5 million |
ALPN Net Income
No data available :(
ALPN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 193.5 million | - | 10.2 million |
2023-06-30 | 203.8 million | - | 10.4 million |
2023-03-31 | 194.9 million | - | 10.6 million |
2022-12-31 | 237.6 million | - | 10.8 million |
ALPN Shares Outstanding
ALPN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1000 | 19.2 million | 5.4 million | - |
2023-06-30 | 279000 | 19.2 million | 5.0 million | - |
2023-03-31 | 93000 | 19.6 million | 5.4 million | - |
2022-12-31 | 116000 | 18.8 million | 4.4 million | - |
ALPN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 10.0 million | 146000 |
2023-06-30 | 8.6 million | 142000 |
2023-03-31 | 9.4 million | 140000 |
2022-12-31 | 2.8 million | 145000 |
ALPN
Price: $64.56
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -22.30
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 35394
Ebitda: 2.3 millionMarket Capitalization: 2.6 billion